As life expectancy continues to rise, scientists are increasingly focused on a different question: how can we age well?
While modern medicine has helped people live longer, age-related cognitive decline, memory loss and neurodegenerative conditions such as Alzheimer’s disease remain significant challenges. Researchers at UC Berkeley are now investigating whether psilocybin, the naturally occurring compound found in certain mushroom species, could play a role in supporting healthy brain ageing.
A First-Of-Its-Kind Study
The Berkeley Centre for the Science of Psychedelics has launched the PLASTICITY study, a groundbreaking project designed to explore how psilocybin affects the ageing brain. The research focuses on adults aged 60 to 85 and uses advanced brain imaging alongside cognitive assessments to measure changes before and after a psilocybin experience.
The goal is simple but ambitious: to determine whether psilocybin can enhance neuroplasticity in older adults.
What Is Neuroplasticity?
Neuroplasticity refers to the brain’s ability to adapt, reorganise and form new neural connections throughout life.
When we’re young, the brain is highly adaptable. As we age, this flexibility gradually declines, making it harder to learn new skills, recover from injury and maintain cognitive performance.
Many researchers believe that preserving or enhancing neuroplasticity could be key to maintaining cognitive health later in life.
Why Are Scientists Interested In Psilocybin?
Previous research has shown that psilocybin may temporarily increase communication between different brain regions and encourage greater neural flexibility. Studies have also observed lasting changes in brain activity and psychological wellbeing following a single guided experience.
Researchers hope that these effects may extend beyond mental health applications and potentially support healthy ageing.
The Berkeley team is specifically investigating whether psilocybin may help older brains maintain adaptability, resilience and cognitive function as people age.
Could Psychedelics Help Protect The Ageing Brain?
At this stage, nobody knows for certain.
The PLASTICITY study is designed to answer exactly that question. While early evidence surrounding neuroplasticity is promising, much more research is needed before any conclusions can be drawn about preventing cognitive decline or neurodegenerative disease.
Scientists are approaching the topic carefully and emphasise that this research is exploratory.
Why This Matters
With populations ageing worldwide, the search for new approaches to maintaining brain health has never been more important.
Whether psilocybin ultimately proves to be part of that solution remains to be seen. What is clear is that research into psychedelics continues to move beyond mental health and into broader questions about how the brain changes throughout life.
The results of studies like PLASTICITY could help us better understand not only ageing, but the remarkable ability of the human brain to adapt and change.
Final Thoughts
The idea that a naturally occurring compound could help support healthy brain ageing is certainly intriguing. While it’s still early days, the launch of this study highlights how psychedelic research is continuing to evolve and explore new frontiers in neuroscience.
As always, we’ll be keeping a close eye on the science and sharing new developments as they emerge.
For microscopy and research discussion purposes only. This article is intended to discuss published scientific research and should not be interpreted as medical advice.
